depletion of the endoplasmic reticulum (ER) resulting in translocation of the transmembrane Ca 2+ sensor protein, stromal interaction molecule 1 (STIM1), to the junctions between ER and the plasma membrane (PM) where it binds to the Ca 2+ channel protein Orai1 to activate Ca 2+ influx. Using confocal and total internal reflection fluorescence microscopy we studied redistribution kinetics of fluorescence-tagged STIM1 and Orai1 as well as SOCE in insulin-releasing β-and glucagon-secreting α-cells within intact mouse and human pancreatic islets. ER Ca 2+ depletion triggered accumulation of STIM1 puncta in the subplasmalemmal ER where they coclustered with Orai1 in the PM and activated SOCE. Glucose, which promotes Ca 2+ store filling and inhibits SOCE, stimulated retranslocation of STIM1 to the bulk ER. This effect was evident at much lower glucose concentrations in α-than in β-cells consistent with involvement of SOCE in the regulation of glucagon secretion. Epinephrine stimulated subplasmalemmal translocation of STIM1 in α-cells and retranslocation in β-cells involving raising and lowering of cAMP, respectively. The cAMP effect was mediated both by protein kinase A and Exchange protein directly activated by cAMP (Epac). However, the cAMPinduced STIM1 puncta did not cocluster with Orai1 and there was no activation of SOCE. STIM1 translocation can consequently occur independently of Orai1 clustering and SOCE.
Based on studies in non-excitable cells Putney proposed the existence of a storeoperated or capacitative pathway for Ca 2+ entry into cells (1) . The store-operated Ca 2+ entry (SOCE) through the plasma membrane (PM) is activated by release of Ca 2+ from the endoplasmic reticulum (ER) in response to Ca 2+ -mobilizing messengers like inositol 1,4,5-trisphosphate (IP 3 ). Some of the released Ca 2+ is inevitably transported out of the cell and the SOCE compensates for this loss and ensures proper Ca 2+ refilling of the ER. The molecular mechanisms underlying the SOCE remained elusive for almost 2 decades until it was discovered that the stromal interacting molecule 1 (STIM1) has a role in store-operated entry (2, 3) . STIM1 and the structurally related STIM2 are single pass transmembrane molecules in the ER and STIM proteins are also present in the PM (4) . Both molecules contain Ca 2+ -sensing EF-hand motifs in their N-termini facing the ER lumen and are believed to sense the Ca 2+ depletion that activates SOCE (3, 5, 6) . Another molecule in the PM named Orai was identified as an important player in the store-operated mechanism (7) (8) (9) . There are three isoforms of Orai (Orai1-3) and evidence accumulated that Orai is the poreforming unit of the store-operated channel (10) (11) (12) (13) (14) . Emptying of Ca 2+ from the ER results in dissociation of the ion from STIM1, which rapidly moves and aggregates in the subplasmalemmal ER where it forms distinct puncta (3, 12, 15, 16) , and this is the site where STIM interacts with Orai to activate SOCE (11, 17, 18) .
The store-operated pathway is also present in excitable cells like the insulinreleasing β-and glucagon-secreting α-cells. Although these cells have more potent voltage-operated routes for Ca 2+ entry, SOCE has been found important for different cellular processes. However, even maximally activated SOCE has modest effects on the cytoplasmic Ca 2+ concentration ([Ca 2+ ] i ) in β- (19) (20) (21) and α-cells (22) , and has mostly been attributed a functional role based on the depolarizing effect (22) (23) (24) . Whereas Ca 2+ depletion of the ER has little effect on the membrane potential (20) and insulin release (24) from β-cells exposed to a substimulatory glucose concentration (3mM), such depletion further depolarizes glucosestimulated β-cells (23) and amplifies insulin secretion (23, 24) . Activation of SOCE has much more important effects on the α-cell by triggering Ca 2+ entry through voltage-operated Ca 2+ channels (VOCCs) (22) and glucagon release (24) , and SOCE has been attributed a central function in epinephrine stimulation and glucose inhibition of glucagon secretion (22, 24) . Studies of the store-operated mechanism in primary β-(21,25) and α-cells (22) entry was controlled by similar low glucose concentrations in α-cells as those regulating release of the glucose-elevating hormone. We also discovered that cAMP triggers STIM1 translocation to the subplasmalemmal regions but neither induce co-clustering of STIM1-Orai1 nor the activation of SOCE that occur after calcium depletion of the ER. The data indicate that STIM1 translocation can occur independent of Orai1 clustering and SOCE.
EXPERIMENTAL PROCEDURES
Chemicals-Epinephrine, cyclopiazonic acid
EGTA, HEPES, and methoxyverapamil were purchased from Sigma (St Louis, MO), and RPMI1640 and fetal bovine serum from Invitrogen (Carlsbad, CA). Biolog Life Science Institute (Bremen, Germany) supplied N6-phenyladenosine-3', 5'-cyclic monophosphate (6-Phe-cAMP), 8-(4-Chlorophenylthio)adenosine-3', 5'-cyclic monophosphorothioate, Sp-isomer (Sp-8-CPTcAMPS), and 8-(4-Chlorophenylthio)-2'-O-methyl-adenosine-3', 5'-cyclic monophosphate, acetoxymethyl ester (8-CPT-AM). The acetoxymethyl ester of the Ca 2+ indicator Fura-PE3 was obtained from TEFLabs (Austin, TX). Tris was from Merck (Darmstadt, Germany), diazoxide from Schering-Plough (Rathdrum, Ireland), serum-free Protein Block, rabbit anti-glucagon and guinea pig anti-insulin were bought from DAKO (Glostrup, Denmark). The MACH 3 TM rabbit-probe alkaline phosphate polymer kit was from Biocare (Concord, CA). MayerHemotoxylin was bought from HistoLab (Gothenburg, Sweden). Adenoviruses expressing STIM1-YFP and Orai1-mCherry were produced as previously described (16) .
Islet isolation, cell culture, and virus infection-All procedures for animal handling, preparation and use of pancreatic islets were approved by local animal and human ethical committees. Islets of Langerhans were isolated from C57BL6J female mice. The animals were placed in a sealed container into which a stream of CO 2 was delivered. When the animals became unconscious they were exsanguinated by decapitation. After opening the peritoneal cavity, the splenic part of pancreas was excised and cut into small pieces, which were digested with 1 mg/ml collagenase to obtain free islets of Langerhans. Human pancreatic islets from five normoglycemic cadaveric donors (two female, three male; aged 39-57 yr) were generously provided by the Nordic Network for Clinical Islet Transplantation. The islets were isolated with semiautomated digestion filtration (27) and purified on a continuous density gradient in a refrigerated cell processor (COBE 2191; COBE Blood Component Technology, Lakewood, CO). After purification the islets were kept for 2-5 days at 37°C in an atmosphere of 5% CO 2 in CMRL 1066 culture medium (Mediatech, Herndon, VA) containing 5.5 mM glucose and supplemented with 10 mM nicotinamide, 10 mM HEPES, 0.25 µg/ml Fungizone, 50 µg/ml gentamicin, 2 mM glutamine, 10 µg/ml ciprofloxacin, and 10% heat-inactivated human serum. The islets were subsequently cultured for 1-4 days in RPMI 1640 medium containing 5.5 mM glucose and supplemented with 10% fetal calf serum, 100 µg/ml penicillin and 100 µg/ml streptomycin. The islets were then infected with adenovirus encoding STIM1-YFP and/or Orai1-mCherry using a multiplicity of infection of 10 5 fluorescent focus-forming units/islet in culture medium. After 1 hour incubation at 37°C, the inoculum was removed and the islets were washed twice, followed by further culture for 24 hr. To check that fluorescence changes did not merely reflect alterations of membrane properties and/or cell adhesion some measurements were performed after co-infection with adenovirus encoding cyan fluorescent protein (CFP) anchored to the PM as reference (28) . Before the experiments, the islets were transferred to a buffer containing 125 mM NaCl, 4.8 mM KCl, 1.3 mM CaCl 2 , 1.2 mM MgCl 2 , and 25 mM HEPES (with pH adjusted to 7.40 with NaOH) and incubated for 30 min at 37°C. The islets were then allowed to attach to the center of poly-lysine-coated round 25 mm coverslips for 5 min. Some experiments were performed on single cells prepared by shaking the freshly isolated islets in a Ca 2+ -deficient medium (29) . After resuspension in the RPMI 1640 culture medium, the cells were allowed to attach to the center of round coverslips during 2-5 days of culture at 37°C in an atmosphere of 5% CO 2 in humidified air. The Metafluor software controlled the monochromator and the camera, acquiring image pairs every 2 s with 80-100 ms integration at each wavelength and <1 ms for changing wavelength and slits. To reduce photodamage the specimens were illuminated only during image capture. Ratio frames were calculated after background subtraction, and [Ca 2+ ] i was estimated as previously described (30) .
Measurements
Cell identification-Immediately after experiments α-and β-cells remaining in position within the experimental chamber in the microscope were identified by immunostaining for glucagon and insulin. The cells were fixed by sequential exposure to 25, 50, 75 and 95% ethanol during 5 min. After sequential rinsing with 3% H 2 O 2 and Tris buffer (0.05 M, pH 7.4) Protein Block was added to reduce background staining. After 10 min, polyclonal rabbit anti-glucagon or guinea pig anti-swine insulin (1:100; DAKO) was added for 30 min followed by rinsing with Tris buffer. The MACH 3 TM rabbit probe alkaline phosphatase polymer kit was then used for the visualization according to manufacturer's instructions. After further rinsing with Tris buffer and distilled water, cell nuclei were stained with hematoxylin for 0.5-2 min. The α-cells are smaller than the β-cells and the two cell types show opposite responses to epinephrine with regard to STIM1-YFP translocation between the bulk ER and the subplasmalemmal junctions (see Results). Therefore, the size of the cell footprint together with the translocation response to epinephrine was used for cell identification in most experiments. These criteria should eliminate the small somatostatin-releasing δ-cells with β-cell-like domination of α 2 adrenoceptors (31) The STIM1-YFP concentration in the subplasmalemmal region was evaluated as the fluorescence intensity F in relation to the initial fluorescence intensity F 0 after subtraction of background (F/F 0 ). To quantify the redistribution of Orai1 in the PM we analyzed the intensity variability in the Orai1 images by calculating the variation coefficient of pixel intensities. The pixel size was 266 nm, which is close to the theoretical 222 nm optical resolution in 645 nm light. Data are presented as means ± SEM. Statistical comparisons were assessed with Student's t test.
RESULTS

Depletion of ER Ca
2+
induces subplasmalemmal STIM1 accumulationPeripheral cells in isolated mouse islets expressing STIM1-YFP and exposed to 3 mM glucose showed diffuse fluorescence over the cytoplasm in confocal microscopy ( Fig. 1A) , but also some subplasmalemmal fluorescence puncta were observed with TIRF microscopy (Fig. 1B) . Depletion of the ER Ca 2+ stores by inhibition of the sarcoendoplasmic reticulum Ca 2+ -ATPase (SERCA) with CPA, induced after a delay of 118 ± 21 s (n=13) gradual formation of much more conspicuous subplasmalemmal puncta (52 ± 4 s rise time; Fig. 1A, B) . Omission of extracellular Ca 2+ with addition of EGTA induced a less marked subplasmalemmal accumulation of STIM1-YFP that was further enhanced by CPA (Fig. 1C) .
The cholinergic agonist carbachol (50 µM), which raises IP 3 and mobilizes ER Ca 2+ both in α- (22) and β-cells (19), induced sustained subplasmalemmal accumulation of STIM1-YFP preceded (3 of 8) or not by an initial peak in most islet cells exposed to 3 mM glucose (Fig. 1D) . Both the delay before the onset of STIM1 translocation (28 ± 4 s; n=8) and the rise time (22 ± 4 s) were much shorter, than after CPA exposure (4-and 2.4-fold difference, respectively p<0.001).
Epinephrine induces opposite translocation of STIM1 in α-and β-cellsIn the presence of 3 mM glucose the addition of 5 µM epinephrine induced opposite responses in different cells. In the majority of the cells (27 of 41) TIRF microscopy revealed epinephrine-induced loss of PM-associated STIM1-YFP fluorescence indicating retranslocation of the protein from the subplasmalemmal region into the bulk ER ( Fig. 2A) . In 5 of the 41 cells that had smaller footprints, epinephrine instead induced pronounced subplasmalemmal accumulation of STIM1-YFP with formation of distinct puncta. Fig. 2B shows that one of the latter cells also responded to CPA with similar STIM1-YFP translocation to the PM. There was no epinephrine response in the remaining 9 cells (not shown). Immunostaining for insulin and glucagon revealed that the epinephrine-induced decrease and increase of subplasmalemmal STIM1-YFP occurred in β-(not shown) and α-cells (Fig. 2C) , respectively.
Glucose stimulates re-translocation of STIM1 to the bulk ER-Increase of the glucose concentration from 3 to 20 mM resulted in loss of subplasmalemmal STIM1-YFP fluorescence in β-cells identified by size and epinephrine response (21 of 32; Fig. 3 ). In most cases this glucose effect was only partially reversed after reintroduction of 3 mM glucose (Fig.  3A) and rapid restoration of subplasmalemmal STIM1-YFP fluorescence required glucose omission (Fig. 3B, C) . Also size-and epinephrine-identified α-cells responded to glucose with reduction of PM-associated STIM1-YFP fluorescence (Fig 4A) . Since this effect was maximal when glucose had been increased from 0 to 3 mM, we tested additional concentrations within this range. (Figs. 4A, 6B) .
The glucose-induced STIM1-YFP retranslocation from the subplasmalemmal region to the bulk ER was also studied in human pancreatic islets. Fig. 5A and B show traces obtained with epinephrineidentified β-cells and that in Fig 5C from an α-cell. Like in mouse β-cells glucose induced concentration-dependent translocation, but at ≥7 mM the gradual reduction of subplasmalemmal fluorescence was interrupted by peaks of PM fluorescence in all of 5 β-cells (Fig.  5A) (Fig. 5C) .
cAMP induces subplasmalemmal STIM1 accumulation involving PKA and Epac-Since epinephrine acts on α 1 (32) and β adrenoceptors (32, 33) in α-cells to increase IP 3 and cAMP (34) resulting in Ca 2+ release from the ER it was not surprising that epinephrine induced subplasmalemmal accumulation of STIM1-YFP. However, the opposite effect in β-cells was unexpected considering that epinephrine acts on α 2 adrenoceptors (33,35) to lower cAMP (34) . We therefore tested whether changes in cAMP might be involved in the STIM1 translocation responses of the two cell types. These experiments were done at a basal glucose concentration to prevent cAMP from promoting IP 3 -receptor-mediated Ca 2+ release, which only occurs in β-cells exposed to higher concentrations of the sugar (36, 37 (38) should not influence the results. Fig. 6A and B show that rise of cAMP by activation of adenylyl cyclases with 5 µM forskolin increased STIM1-YFP translocation to the PM in 22 of 27 β-cells with opposite response to epinephrine. Also most epinephrineidentified α-cells (6 of 8) reacted to forskolin in a similar manner (Fig. 6B) and the remaining α-cells did not respond (Fig.  6A) . Figs. 6C and D illustrate that STIM1-YFP translocation to the PM after rise of cAMP by phosphodiesterase inhibition with 50 µM IBMX is reversed by 100 µM of the adenylyl cyclase inhibitor DDA in all of 10 β- (Fig. 6C ) and all of 9 α-cells (Fig. 6D) identified with epinephrine. Also the specific PKA agonists 6-Phe-cAMP (100 µM) induced STIM1-YFP translocation to the PM in 11 of 17 β- (Fig.  6E ) and 6 of 10 α-cells (not shown) identified with epinephrine, and similar effects were seen with another PKA activator (100 µM Sp-8-CPT-cAMPS; not shown). However, elevation of cAMP with forskolin induced additional PM translocation of STIM1-YFP (Fig. 6E, 6 of 8 β-cells). We therefore also tested the effect of 1-2 µM of the Epac activator 8-CPT-AM, which also induced STIM1-YFP translocation to the PM in 16 of 26 β- (Fig.  6F ) and 7 of 11 α-cells (not shown) identified with epinephrine. Our data therefore indicate that both PKA and Epac contribute to mediate the effect of cAMP on STIM1-YFP translocation to the PM.
cAMP-stimulated STIM1 translocation does not activate SOCE-The effects of cAMP modulation on SOCE were studied using a Ca 2+ omission-readdition approach in cells that were hyperpolarized with diazoxide and exposed to the Ca 2+ channel blocker methoxyverapamil to prevent voltage-operated Ca 2+ entry. The β-cell in Fig. 7A was initially ] i by 66 ± 8 nM (n=7; P<0.005). Also under these conditions forskolin failed to affect the response (67 ± 9 nM; n=7).
The effect of cAMP elevation with forskolin on SOCE was also tested in in the presence of 20 mM glucose that maximally fills the ER with Ca 2+ (19) and inhibits the store-operated pathway (21, 25) as well as under conditions when this pathway was activated with CPA (Fig.  7B) . Again forskolin had no effect on the Ca 2+ readdition-induced elevation of [Ca 2+ ] i under either of these conditions. Before addition of CPA the increase was 15 ± 5 nM both in the absence and presence of forskolin, and after addition of CPA the increases were 55 ± 4 nM and 50 ± 4 nM (n=6) in the absence and presence of forskolin, respectively. cAMP-induced accumulation of subplasmalemmal STIM1 apparently occur without effect on SOCE.
cAMP-stimulated STIM1 translocation does not induce STIM1-Orai1 coclustering-Searching for an explanation why cAMP-induced STIM1 translocation did not activate SOCE we next studied Orai1 distribution in the PM of islet cells expressing Orai1-mCherry alone (not shown) or in combination with STIM1-YFP (Fig. 8) . When the SERCA pump was energized by the presence of 20 mM glucose to fill the ER with calcium and the cells hyperpolarized with diazoxide to prevent triggering of CICR there were few STIM1-YFP puncta at the PM (Fig. 8A top  panels) . The number of puncta increased markedly in response to forskolin and the effect was even more striking after depletion of ER Ca 2+ with CPA. The more pronounced effect of CPA than of forskolin was preferentially observed when STIM1 was co-expressed with Orai-1. In cells expressing STIM1-YFP alone the total PM-associated STIM1-YFP fluorescence increased 1.64 ± 0.19-fold in the presence of forskolin and 1.82 ± 0.21-fold (not significant; n=6) of control during subsequent exposure to CPA. However, after co-expression with Orai1-mCherry the total PM-associated STIM1-YFP fluorescence in response to forskolin was 1.31 ± 0.16-fold and that induced by CPA 2.25 ± 0.24-fold (P<0.001; n=8) of control.
Under control conditions Orai1-mCherry showed a diffuse distribution with even PM fluorescence and no apparent effect of exposure to forskolin. The variation coefficients in pixel intensities under these conditions were identical (10.2 ± 0.3% for control and 10.3 ± 0.2% for forskolin). However, subsequent SERCA inhibition with CPA induced Orai1-mCherry redistribution with formation of a punctate pattern (Fig. 8A , middle panels) resulting in a highly significant (P=0.001) increase of the variation coefficient to 13.5 ± 0.4%. The CPA-induced Orai1-mCherry puncta colocalized with those of STIM1-YFP whereas STIM1-YFP puncta formed in response to forskolin did not associate with increased Orai1-mCherry (Fig 8A, bottom  panels) . To quantify the changes in STIM1 and Orai1, regions of interest (ROIs) were selected corresponding to STIM1-puncta formed either in response to CPA or forskolin, and the STIM1-YFP and Orai1-mCherry fluorescence was then measured in these ROIs. Fig. 8B shows that the STIM1-YFP fluorescence within ROIs defined by CPA-induced STIM1-YFP puncta showed a less pronounced increase during exposure to forskolin. However, the Orai1-mCherry fluorescence within these ROIs only increased in response to CPA (Fig 8C) . When the ROIs were instead defined by STIM1-YFP puncta formed in response to forskolin, the STIM1-YFP fluorescence within these ROIs also increased after exposure to CPA (Fig. 8D) . The Orai1-mCherry fluorescence within the same ROIs was not different under basal conditions and in the presence of forskolin but tended to decrease slightly after exposure to CPA (Fig. 8E) . Orai1 consequently only associates with STIM1 after Ca 2+ depletion of the ER, and preferentially at sites other than those where STIM1 forms puncta in response to forskolin. This conclusion was supported by comparing the location of STIM1 puncta formed in response to forskolin and CPA. As seen in Fig. 8F there was relatively little overlap (yellow) between STIM1-YFP puncta formed in response to forskolin (displayed in red) and those formed after exposure to CPA (displayed in green).
DISCUSSION
The present study shows that Ca 2+ release from the ER and sequestration of the ion in this organelle in the insulin-and glucagon-releasing pancreatic islet cells cause the characteristic translocations of STIM1 to and from the subplasmalemmal junctions, respectively. It also demonstrates that epinephrine mimics the effect of Ca 2+ store depletion in inducing subplasmalemmal accumulation of STIM1 in α-cells but that the opposite effect is observed in β-cells. Searching for the underlying mechanism we found that cAMP, which increases and decreases in response to epinephrine in α-and β-cells, respectively (34) , is involved in the subplasmalemmal accumulation of STIM1. Since the dynamin-related mitochondrial protein mitofusin 2, which was recently implicated in the trafficking of STIM1 to the ER-PM junctions (39) , is regulated by PKA (40), we speculate that this mechanism partakes in the cAMP-induced STIM1 translocation. Additional processes are likely involved, as translocation was induced both by specific PKA and Epac agonists. However, whereas the STIM1 translocation determined by the filling state of the ER, affected STIM1-Orai1 coclustering and modulated SOCE as expected, translocation determined by cAMP occurred without effects on Orai1 and Ca 2+ entry. Activation of SOCE by Ca 2+ store depletion has been found to involve a conformational transition that releases the Orai-activating region of STIM1 from an intramolecular clamp (41, 42) . Our data indicate that cAMP induces STIM1 translocation independent of such a conformational change.
Glucose is the major physiological stimulator of insulin secretion. The sugar is taken up and metabolized by the β-cells resulting in increased ATP production. An early effect of glucose stimulation is therefore to energize the SERCA pump causing calcium sequestration in the ER, lowering of [Ca 2+ ] i (20, 43) and initial inhibition of insulin secretion (44, 45) . The increased ATP/ADP ratio also closes K ATP channels in the PM with ensuing depolarization. Subsequent opening of Ltype VOCCs results in entry of Ca 2+ and a rise of [Ca 2+ ] i that triggers a pronounced peak of secretion replacing the initial inhibition (46) . ER sequestration of Ca 2+ is half-maximal and maximal at about 6 and 20 mM glucose, respectively (19, (47) (48) (49) . It is well documented that Ca 2+ emptying of the ER activates SOCE in β-cells (19) (20) (21) 23, 25, 50) and the rate of SOCE is inversely dependent on the Ca 2+ filling of the ER in a graded fashion (25) . The presently observed glucose-induced STIM1 retranslocation from the PM to the cell interior in mouse β-cells showed somewhat higher glucose sensitivity than Ca 2+ filling of the ER with half-maximal and maximal effects at 3.4 and 11 mM respectively. Human β-cells were similar in this respect but CICR may be more prominent in the human cells explaining why peaks of near-membrane STIM1-YFP fluorescence interrupted glucose-induced STIM1 disappearance from the subplasmalemmal region. The physiological relevance of the glucose effects on ER Ca 2+ filling in β-cells is probably to secure a pool of releasable Ca 2+ rather than regulating the storeoperated pathway, which has modest effects on [Ca 2+ ] i and insulin secretion (20, 21, 23, 25) .
The glucose sensitivity of STIM1 retranslocation to the ER was strikingly higher in α-than in β-cells with maximal effect at 3 mM reinforcing indirect observations that this concentration is sufficient for maximal Ca 2+ filling of the α-cell ER (22) . The different glucose sensitivities cannot be attributed to the fact that α-cells only express SERCA2b whereas the β-cell also express the lower affinity Ca 2+ transporter SERCA3 (51). The glucose concentration dependence of ER Ca 2+ filling in β-cells is thus unaffected after SERCA3 knockout (52) . SOCE in α-cells is consequently controlled by the same low glucose concentrations that regulate glucagon release. Since α-cells have a higher input resistance than β-cells, the membrane potential is sensitive to small changes in current (53) . Therefore SOCE has a much more pronounced effect in α-cells, depolarizing the membrane sufficiently to trigger Ca 2+ influx through VOCCs (22) and glucagon release (24) . Epinephrine stimulates glucagon secretion in this manner by binding to α 1 and β adrenoceptors (32) leading to ER release of Ca 2+ with resulting SOCE and VOCC activation (22) . We have proposed that also glucose modulates glucagon secretion via the store-operated mechanism. Under normoglycaemic conditions the ER is filled with Ca 2+ and there is no SOCE activation and thus no depolarization to activate the VOCCs. By contrast, when glucose declines to hypoglycaemic levels, the ER begins to empty and the resulting SOCE activation provides the membrane depolarization that triggers VOCC activation and glucagon release (22, 24) .
In summary the present study shows that STIM1 accumulates in the subplasmalemmal region in response to Ca 2+ depletion of the ER in α-and β-cells, and that glucose-induced Ca 2+ refilling of the ER stimulates the opposite translocation. The observation that a glucose concentration as low as 3 mM causes maximal retranslocation of STIM1 to the ER in α-cells is consistent with the idea that the sugar inhibits glucagon secretion by shutting off the store-operated pathway. We also found that cAMP stimulates subplasmalemmal accumulation of STIM1 in both α-and β-cells. However, the cAMP-induced STIM1 puncta formed without co-clustering of Orai1 or activation of SOCE. Apparently, factors in addition to STIM1 translocation are required for the formation of functional Orai1 channels and activation of SOCE. __________________________________ Apart from the size the cells were identified as β-cells based on the lack of response to epinephrine (Epi, 5µM). A, Forskolin does not affect SOCE in a cell exposed to 3 mM glucose. VOCCs were blocked by hyperpolarization with diazoxide and presence of 100 µM methoxyverapamil. The [Ca 2+ ] i response to Ca 2+ omission followed by exposure to 10 mM Ca 2+ was studied under control conditions and in the presence of 5 µM forskolin before and after full activation of SOCE with 100 µM CPA. B, Forskolin does not affect SOCE in a cell exposed to 20 mM glucose. Like in A hyperpolarizing diazoxide and the voltage-operated Ca 2+ channel blocker methoxyverapamil (MV) were present throughout. The [Ca 2+ ] i response to Ca 2+ omission followed by exposure to 10 mM Ca 2+ was studied under control conditions and in the presence of 5 µM forskolin before and after full activation of SOCE with 100 µM CPA. 
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